Position in BMY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$10,334,204
+$157,620 QoQ
Shares Held
179,351
+6.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#383
of 2,506 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CWA Asset Management Group, LLC holds $104,319,210 across 14 Drug Manufacturers - General names. BMY ranks #3 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
97,695 | $24,811,599 | |
| 2 | ABBV |
AbbVie Inc.
|
86,259 | $21,706,214 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
179,351 | $10,334,204 | |
| 4 | LLY |
ELI LILLY & Co
|
7,425 | $8,905,768 | |
| 5 | BIIB |
Biogen Inc.
|
38,127 | $8,237,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,399 | $8,009,829 | |
| 7 | MRK |
Merck & Co., Inc.
|
38,429 | $4,938,126 | |
| 8 | NVS |
Novartis AG
|
29,083 | $4,557,887 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,334,204 | 179,351 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $10,176,584 | 167,792 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $6,206,767 | 115,068 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $6,781,190 | 150,359 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $5,529,340 | 119,450 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $7,069,655 | 115,915 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $6,286,587 | 111,149 | Shares | Sole | 2025-01-06 | |
| 2024-09-30 | $4,511,314 | 87,192 | Shares | Sole | 2024-11-01 | |
| 2024-03-31 | $6,374,085 | 117,538 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,305,275 | 25,439 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $470,530 | 8,107 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $500,344 | 7,824 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $439,356 | 6,339 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $705,685 | 9,808 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $714,667 | 10,053 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $763,301 | 9,913 | Shares | Sole | 2022-07-21 | |
| 2022-03-31 | $724,895 | 9,926 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $389,188 | 6,242 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $412,414 | 6,970 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $424,373 | 6,351 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $443,172 | 7,020 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $435,140 | 7,015 | Shares | Sole | 2021-02-23 | |
| 2020-09-30 | $450,306 | 7,469 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $490,274 | 8,338 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $518,995 | 9,311 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||